Publications by authors named "Henrik T Vestergaard"

Claim this Profile
U
US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development.
Anne Vinther Morant, Henrik Tang Vestergaard, Anders Blaedel Lassen, Vaidrius Navikas

Clin Transl Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders.
Anne Vinther Morant, Vivien Jagalski, Henrik Tang Vestergaard

Front Med (Lausanne)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non-orphan, Non-oncology Drugs in the European Union and United States from 2012-2016.
Anne Vinther Morant, Vivien Jagalski, Henrik Tang Vestergaard

Clin Transl Sci· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Marketing Authorizations Granted Based on a Single Pivotal Clinical Trial: The Rule or the Exception?
Anne Vinther Morant, Henrik Tang Vestergaard

Clin Pharmacol Ther· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution of nonclinical regulatory science: advanced therapy medicinal products as a paradigm.
Henrik Tang Vestergaard, Lucia D'Apote, Christian K Schneider, Carla Herberts

Mol Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug-drug interactions.
Anne Sophie Grandvuinet, Henrik Tang Vestergaard, Nicolas Rapin, Bente Steffansen

J Pharm Pharmacol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does brain slices from pentylenetetrazole-kindled mice provide a more predictive screening model for antiepileptic drugs?
Suzanne L Hansen, Zoran Sterjev, Marie Werngreen, Bodil J Simonsen, Katrine E Knudsen, Henrik T Vestergaard

Eur J Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GAD65 is essential for synthesis of GABA destined for tonic inhibition regulating epileptiform activity.
Anne B Walls, Linn Hege Nilsen, Elvar M Eyjolfsson, Henrik T Vestergaard, Suzanne L Hansen

J Neurochem· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological screening of Malian medicinal plants used against epilepsy and convulsions.
Mikael E Pedersen, Henrik T Vestergaard, Suzanne L Hansen, Sekou Bah, Drissa Diallo

J Ethnopharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of extracts of Searsia species on epileptiform activity in slices of the mouse cerebral cortex.
Mikael Egebjerg Pedersen, Henrik Tang Vestergaard, Gary Ivan Stafford, Johannes van Staden, Anna K Jäger

J Ethnopharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in kinetics of structurally related competitive GABA(A) receptor antagonists.
Henrik Tang Vestergaard, Carolina Cannillo, Bente Frølund, Uffe Kristiansen

Neuropharmacology· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
Bente Frølund, Lars S Jensen, Luca Guandalini, Carolina Canillo, Henrik T Vestergaard

J Med Chem· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analogues of homoibotenic acid show potent and selective activity following sensitisation by quisqualic acid.
Henrik T Vestergaard, Stine B Vogensen, Ulf Madsen, Bjarke Ebert

Eur J Pharmacol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibotenic acid and thioibotenic acid: a remarkable difference in activity at group III metabotropic glutamate receptors.
Mette B Hermit, Jeremy R Greenwood, Birgitte Nielsen, Lennart Bunch, Charlotte G Jørgensen, Henrik T Vestergaard

Eur J Pharmacol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel class of potent 4-arylalkyl substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
Bente Frølund, Anne T Jørgensen, Lena Tagmose, Tine B Stensbøl, Henrik T Vestergaard

J Med Chem· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis